Vabysmo - direct healthcare professional communication (DHPC)

Faricimab
DHPCHuman

Swedish is available via eTranslation, the European Commission's machine translation service.

Translate to Swedish | Important information about machine translation

Om

This direct healthcare professional communication (DHPC) contains important information for healthcare professionals prescribing, dispensing or administering the medicine(s). It also includes a communication plan with details of intended recipients and the dissemination date.

Dokument

Key facts

Vabysmo
Active substance
Faricimab
Therapeutic area (MeSH)
  • Wet Macular Degeneration
  • Macular Edema
  • Diabetes Complications
DHPC type
Quality defect
Human ATC codes
S01L
Dissemination date

Share this page